Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Chinn

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Pain and Headache Reports|February 29, 2016
Fibromyalgia Pathogenesis and Treatment Options UpdateSteven Chinn, William Caldwell, Karina Gritsenko
Otolaryngologic Clinics of North America|May 23, 2023
Practice Trends and Evidence-Based Practice in Microvascular ReconstructionCandace A Flagg, Jayne R Stevens, Steven Chinn
Journal of Neurological Surgery. Part B, Skull Base|April 11, 2014
Sinonasal inverted papilloma: prognostic factors with emphasis on resection marginsGiant C Lin, Sarah Akkina, Steven Chinn, et al.
Oral Oncology|October 15, 2024
Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstructionMicah K Harris, Sophia Dang, Joshua D Smith, et al.
International Forum of Allergy & Rhinology|September 17, 2013
Epidermal growth factor receptor, p16, cyclin D1, and p53 staining patterns for inverted papillomaGiant C Lin, Adam Scheel, Sarah Akkina, et al.
Journal of Cancer Survivorship : Research and Practice|October 20, 2025
Long-term quality of life in head and neck cancer: the role of postdiagnosis smoking behaviorElham Mohebbi, Alaina L Carr, Garret Guthrie, et al.
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell CarcinomaYue Cao, Catherine T Haring, Collin Brummel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
FDG-PET-based Selective De-escalation of Chemoradiation in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma: a Multi-center Phase II TrialMichelle Mierzwa, Benjamin Rosen, Krithika Suresh, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Pain and Headache Reports|February 29, 2016
Fibromyalgia Pathogenesis and Treatment Options UpdateSteven Chinn, William Caldwell, Karina Gritsenko
Otolaryngologic Clinics of North America|May 23, 2023
Practice Trends and Evidence-Based Practice in Microvascular ReconstructionCandace A Flagg, Jayne R Stevens, Steven Chinn
Journal of Neurological Surgery. Part B, Skull Base|April 11, 2014
Sinonasal inverted papilloma: prognostic factors with emphasis on resection marginsGiant C Lin, Sarah Akkina, Steven Chinn, et al.
Oral Oncology|October 15, 2024
Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstructionMicah K Harris, Sophia Dang, Joshua D Smith, et al.
International Forum of Allergy & Rhinology|September 17, 2013
Epidermal growth factor receptor, p16, cyclin D1, and p53 staining patterns for inverted papillomaGiant C Lin, Adam Scheel, Sarah Akkina, et al.
Journal of Cancer Survivorship : Research and Practice|October 20, 2025
Long-term quality of life in head and neck cancer: the role of postdiagnosis smoking behaviorElham Mohebbi, Alaina L Carr, Garret Guthrie, et al.
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell CarcinomaYue Cao, Catherine T Haring, Collin Brummel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2025
FDG-PET-based Selective De-escalation of Chemoradiation in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma: a Multi-center Phase II TrialMichelle Mierzwa, Benjamin Rosen, Krithika Suresh, et al.
Pageof 1